These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21995655)

  • 1. Central functions of neuropeptide Y in mood and anxiety disorders.
    Wu G; Feder A; Wegener G; Bailey C; Saxena S; Charney D; Mathé AA
    Expert Opin Ther Targets; 2011 Nov; 15(11):1317-31. PubMed ID: 21995655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
    Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
    Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NPY system in stress, anxiety and depression.
    Heilig M
    Neuropeptides; 2004 Aug; 38(4):213-24. PubMed ID: 15337373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases.
    Pons J; Lee EW; Li L; Kitlinska J
    Curr Opin Investig Drugs; 2004 Sep; 5(9):957-62. PubMed ID: 15503651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
    Desai SJ; Borkar CD; Nakhate KT; Subhedar NK; Kokare DM
    Neuroscience; 2014 Sep; 277():818-30. PubMed ID: 25106129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
    Rimondini R; Thorsell A; Heilig M
    Neurosci Lett; 2005 Feb; 375(2):129-33. PubMed ID: 15670655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies.
    Harro J
    Amino Acids; 2006 Oct; 31(3):215-30. PubMed ID: 16738800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between NPY and CRF in the amygdala to regulate emotionality.
    Sajdyk TJ; Shekhar A; Gehlert DR
    Neuropeptides; 2004 Aug; 38(4):225-34. PubMed ID: 15337374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
    Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
    dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD
    Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
    Morales-Medina JC; Dumont Y; Benoit CE; Bastianetto S; Flores G; Fournier A; Quirion R
    Neuropharmacology; 2012 Jan; 62(1):200-8. PubMed ID: 21803058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
    Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
    Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.
    Trent NL; Menard JL
    Physiol Behav; 2013 Feb; 110-111():20-9. PubMed ID: 23274501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide y: role in emotion and alcohol dependence.
    Carvajal C; Dumont Y; Quirion R
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):181-95. PubMed ID: 16611091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive.
    Munglani R; Hudspith MJ; Hunt SP
    Drugs; 1996 Sep; 52(3):371-89. PubMed ID: 8875128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
    Trent NL; Menard JL
    Pharmacol Biochem Behav; 2011 Oct; 99(4):580-90. PubMed ID: 21693128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.